Results
1 -
10 of
32Simard et al..
A new screening assay for allosteric inhibitors of cSrc, Nature Chemical Biology, 2009 Koeberle et al..
Skepinone-L is a selective p38 mitogen-activated protein kinase inhibitor, Nature Chemical Biology, 2011 Zhang Jian-Ting, He Dan, Zhao Xiao-qin, Chen Xing-gui, Fang Yi, Singh Satyakam, Talele Tanaji T., Qiu Hui-juan, Liang Yong-ju, Wang Xiao-kun, Zhang Guo-qing, Chen Zhe-sheng, Fu Li-wu.
BIRB796, the Inhibitor of p38 Mitogen-Activated Protein Kinase, Enhances the Efficacy of Chemotherapeutic Agents in ABCB1 Overexpression Cells, PLoS ONE, 2013 Genovese Mark C..
Inhibition of p38: Has the fat lady sung?, Arthritis & Rheumatism, 2009 Boije af Gennäs Gustav, Mologni Luca, Ahmed Shaheen, Rajaratnam Mohanathas, Marin Oriano, Lindholm Niko, Viltadi Michela, Gambacorti-Passerini Carlo, Scapozza Leonardo, Yli-Kauhaluoma Jari.
Design, Synthesis, and Biological Activity of Urea Derivatives as Anaplastic Lymphoma Kinase Inhibitors, ChemMedChem, 2011 Fischer Stefan, Wentsch Heike K., Mayer-Wrangowski Svenja C., Zimmermann Markus, Bauer Silke M., Storch Kirsten, Niess Raimund, Koeberle Solveigh C., Grütter Christian, Boeckler Frank M., Rauh Daniel, Laufer Stefan A..
Dibenzosuberones as p38 Mitogen-Activated Protein Kinase Inhibitors with Low ATP Competitiveness and Outstanding Whole Blood Activity, Journal of Medicinal Chemistry, 2013 A. Messoussi, G. Chevé, K. Bougrin, A. Yasri.
4 Nasiri Amir H., Saxena Krishna, Bats Jan W., Nasiri Hamid R., Schwalbe Harald.
Biophysical investigation and conformational analysis of p38α kinase inhibitor doramapimod and its analogues, Med. Chem. Commun., 2016 Petersen L. K., Blakskjær P., Chaikuad A., Christensen A. B., Dietvorst J., Holmkvist J., Knapp S., Kořínek M., Larsen L. K., Pedersen A. E., Röhm S., Sløk F. A., Hansen N. J. V..
Novel p38α MAP kinase inhibitors identified from yoctoReactor DNA-encoded small molecule library, Med. Chem. Commun., 2016